INDRAMEDCO vs SHALBY: Stock Comparison

Indraprastha Medical Corporation Limited vs Shalby Limited

Live data: 16 July 2026, 12:37 PM IST • Source: NSE and company filings

Indraprastha Medical Corporation Limited is the larger company by market capitalisation. Indraprastha Medical Corporation Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Indraprastha Medical Corporation Limited and Shalby Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDRAMEDCO is more favourable on 11 of 13 scored metrics and SHALBY on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
INDRAMEDCO is the larger company
₹3,437 Cr vs ₹1,802 Cr
P/E Ratio
INDRAMEDCO has a lower P/E
19.06x vs 49.42x
P/B Ratio
SHALBY has a lower P/B
1.84x vs 4.73x
EPS
INDRAMEDCO has higher earnings per share
₹20.04 vs ₹3.23
Dividend Yield
INDRAMEDCO has a higher dividend yield
1.19% vs 0%
Revenue Growth (TTM YoY)
INDRAMEDCO has faster revenue growth
9.3% vs 8.5%
EPS Growth (TTM YoY)
INDRAMEDCO has faster EPS growth
1.8% vs 0%
Qtr Sales Growth
INDRAMEDCO has stronger quarterly sales growth
9.31% vs 8.52%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDRAMEDCOSHALBY
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricINDRAMEDCOSHALBY
Live Price₹375.7₹167.09
Day Change-0.32%-0.68%
Volume54,63172,970
52-Week High₹640.85₹274.7
52-Week Low₹342₹125.82
Distance from 52W High-41.37%-39.17%

Valuation

MetricINDRAMEDCOSHALBY
Market Cap₹3,437 Cr₹1,802 Cr
P/E Ratio19.06x49.42x
P/B Ratio4.73x1.84x
EPS₹20.04₹3.23
Book Value₹80.78₹94.39
Dividend Yield1.19%0%

Growth

MetricINDRAMEDCOSHALBY
Revenue Growth (TTM YoY)9.3%8.5%
EPS Growth (TTM YoY)1.8%0%
Qtr Sales Growth9.31%8.52%
Qtr Profit Growth1.68%266%

Profitability & Leverage

MetricINDRAMEDCOSHALBY
ROE27.5%3.74%
ROCE35.8%6.48%
Net Margin12.21%3.28%
Operating Margin18%12.5%
Debt to Equity0x0.01x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricINDRAMEDCOSHALBY
Promoter Holding49.39%74.33%
FII Holding2.44% 0.29 pp4.36% 0.11 pp
DII Holding0.88% 0.05 pp0.25% 0.05 pp
Public Holding45.69% 0.25 pp20.41% 0.06 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Indraprastha Medical Corporation Limited and Shalby Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.